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doi:10.1016/j.ejvs.2008.01.029Abstract Objectives: The association of peripheral arterial occlusive disease (PAD) associa-
tion with major coronary events (MCE) has been well documented, nevertheless data are lack-
ing for populations with a low incidence of coronary heart disease (CHD). We aimed to assess
the association of PAD with MCE in a Mediterranean population.
Design: Prospective survey of 699 55e74 year-old men representative of an urban district near
Barcelona (Spain).
Methods: Baseline cardiovascular risk factors, CHD and PAD (ankle/brachial index< 0.9) were
recorded. MCE were evaluated during the 5-year follow-up.
Results: At recruitment 94 subjects (13.4%) had PAD. During follow-up (mean 69.3 months), 35
(5%) subjects suffered a MCE, of whom 12 had PAD, 9 previous symptomatic CHD and 1 subject
both conditions. Higher CHD related mortality (8.6% vs 1.4%; p< 0.001) and lower MCE-free
survival (78.67% vs 93.26%; p< 0.001) was observed for PAD subjects. On Cox regression
analysis PAD (RRZ 3; pZ 0.003) and previous symptomatic CHD (RRZ 4.1; p< 0.001) were
associated independently with MCE during follow-up.
Conclusions: Even in a population with a low incidence of CHD there is a strong relationship
between PAD and future MCE. Screening for PAD may improve the selection of patients
targeted for cardiovascular risk prevention.
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72 J. Merino et al.Introduction PAD was assessed by rest ankle/brachial pressurePeripheral artery occlusive disease (PAD) has been associ-
ated with coronary heart disease (CHD) morbidity and
mortality in prospective epidemiological studies performed
in populations with a high incidence of cardiovascular
disease. In those studies, subjects with PAD, as measured
by clinical or hemodynamic criteria, showed a 20% to 60%
increased risk of myocardial infarction and a 2- to 6-fold
increased risk of cardiac related death.1e8
However, little is known about the magnitude of these
relationships in populations with low incidence of CHD, as
in the case of the Mediterranean population. Several
epidemiological studies have found that the incidence of
coronary morbidity and mortality in Southern Europe is 2-
to 4-fold lower than in Northern countries.9e11 Primary pre-
vention within populations with low CHD incidence is costly
and the addition of new risk factors to existing scoring
systems may enhance cost-effective strategies for primary
prevention.
The Pubilla-Casas Artery Study12,13 was a study of prev-
alence and risk factors of PAD in 699 adult-old men from
an urban district nearby Barcelona, Spain. In this study
the prevalence of PAD and cardiovascular risk factors
were similar to that observed in other countries with higher
incidence of CHD. The aim of the present analysis was to
evaluate the risk of major coronary events (MCE) in patients
with PAD after 5 years of follow-up.Subjects and Methods
Study population
The target population comprised all 55- to 74-year-old men
of Pubilla Casas, an urban neighbourhood of Barcelona,
Spain. At the time of recruitment (1996e7), 3500 of all
inhabitants in Pubilla Casas were men in this age category,
of whom 85% were registered with the Pubilla Casas Primary
Care Centre, attended by 14 general practitioners. All male
subjects (excluding those with mental disorders or terminal
illnesses) attended by 4 of these general practitioners were
recruited. To improve generalisability, a random sample of
15% of the registered male population of the same age from
4 other practitioners was added. This sampling method
yielded 900 eligible men for the study, of whom 708 agreed
to participate. Informed consent was obtained from all
participants.
Measurements
Cardiovascular risk factors, symptomatic CHD and PAD were
evaluated at the time of recruitment by the 4 general
practitioners who regularly attended the population of
study. Risk factors assessed included age, exposure to
cigarette smoking, alcohol intake, hypertension, diabetes,
body mass index, cholesterol and its fractions and tri-
glycerides. Previous symptomatic CHD or cerebrovascular
events were defined by well documented previous episodes
(hospital discharge sheets or a confirmative cardiologist/
neurologist evaluation).indexes (ABI). ABIs were performed by the 4 principal
general practitioners, using a calibrated mercury sphygmo-
manometer and a handheld Doppler device. Present or
previous symptoms suggestive of PAD were also recorded
from all subjects. Subjects presenting with an ABI below 0.9
or present or past PAD symptoms were referred to the
vascular surgery department of the Hospital del Mar. In all
such causes, clinical history was verified by a vascular
surgeon and ABIs performed in the vascular laboratory.
Definitive diagnosis of PAD was established when an
ABI< 0.9 was confirmed, regardless of symptoms. Nine par-
ticipants had an abnormally high ABI (>1.5) suggestive of
arterial calcification and were excluded from the study.
Follow-up
According to standard clinical criteria, subjects were
followed-up by their four general practitioners. Standard
care was provided with the aim of limiting all cardiovascu-
lar risk factors, including tobacco consumption. Subjects
lost to follow-up, usually because of change of address,
were contacted by telephone. All coronary events were
confirmed by hospital discharge sheets or cardiologist
evaluations. Criteria to define fatal or non-fatal myocardial
infarction (MI) were adapted from those proposed by the
American Heart Association.14 Coronary deaths were con-
firmed by death certificates or hospital records. Sudden
death was considered to be coronary related in all those
cases with previous CHD and no other reasonable cause.
Major coronary events (MCE) were defined as myocardial
infarction (MI) (fatal or non-fatal) or suspected coronary
sudden death.
Statistical methods
Participants were classified according to the presence or
absence of PAD at the beginning of the study. Associations
of future MCE with baseline PAD, CHD and risk factors were
assessed by crude event rates, KaplaneMeier life tables and
Cox proportional hazards models. In order to control for
potential confounding factors, all variables related to PAD
or MCE with p< 0.10 in the bivariate analyses (hyperten-
sion, diabetes mellitus, smoking history> 40 pack-years,
LDL-cholesterol plasma levels> 160 mg/dl, HDL-cholesterol
plasma levels< 35 mg/dl, triglyceride plasma lev-
els> 200 mg/dl, previous cerebro-vascular events and pre-
vious symptomatic CHD) were considered in the
multivariate model. Statistically non-significant variables
not modifying beta-coefficients were retrieved from the
model to increase statistical power. A p-value of< 0.05
was considered statistically significant. All analyses were
performed using SPSS statistical software.
Results
The study included 699 men with a mean age of 64.7 years.
Of these subjects 47.9% were previous smokers and 33.3%
current smokers, 55.5% had hypertension, 20.9% diabetes,
33.8% LDL-cholesterol plasma levels> 160 mg/dl, 8% HDL-
cholesterol plasma levels< 35 mg/dl, and 12.6%
Table 2 Baseline medication of the population of study
PAD (nZ 94)
n (%)
No PAD
(nZ 605)
n (%)
P value
Angiotensin-
converting
enzyme
inhibitors
23 (24.4) 97 (16) 0.03
Calcium
antagonists
14 (14.2) 71 (11.7) NS
b-blockers 1 (1) 20 (3.3) NS
Diuretics 15 (15.9) 50 (8.2) 0.01
Antiplatelet
aggregation
agents
31 (32.9) 56 (9.2) <0.01
Anticoagulants 2 (2.1) 8 (1.3) ns
Lipid lowering
medication
7 (7.4) 56 (9.2) ns
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vascular and CHD events were recorded in 37 (5.3%) and
62 (8.9%) subjects, respectively.
At recruitment, 94 subjects (13.4%) had PAD, of whom 33
(4.7%) were asymptomatic and 61 (8.7%) were, or had been,
symptomatic. Sixty (63.8%) patients had an ABI between
0.61 and 0.9, whereas the remaining 34 (36.2%) had an ABI
of 0.6 or less.
Subjects with PAD were older and had an increased
prevalence of cardiovascular risk factors (smoking expo-
sure, diabetes, hypertension, low HDL-cholesterol and high
triglycerides plasma levels) and CHD (14.9% vs 7.9%,
pZ 0.027) (Table 1). At the recruitment, PAD subjects
were more frequently prescribed angiotensin-converting
enzyme inhibitors, diuretics and antiplatelet agents
(p< 0.05) (Table 2).
Mean follow-up of the cohort was 69.3 months. Within
this period, 91 subjects died (22 CHD-related). Of the
remaining 608 subjects, a minimum of 5-years follow-up
was recorded in 90.1%. During follow-up, 35 (5%) subjects
suffered a major coronary event, of which 21 (60%) were
non-fatal MIs, 10 (28.6%) fatal MIs and 4 (11.4%) coronary
related sudden deaths. Of these subjects, 12 (34.3%) had
PAD alone, 9 (25.7%) had symptomatic CHD and 1 subject
had both conditions at recruitment.
Subjects with PAD at baseline had a lower MCE-free
survival as compared with those without PAD (78.7% vsTable 1 Baseline characteristics of the population
of study
PAD
(nZ 94)
n (%)
No PAD
(nZ 605)
n (%)
P value
Age* 67.13
 5.1
64.39hsp
sp="0.2"/>
 5.13
<0.001
Non smoker 1 (1.1) 130 (21.6)
Previous smoker 39 (49.5) 296 (48.9)
Current smoker 54 (57.4) 179 (29.6) <0.001
Alcohol intake
(gr/day)*
22.78 29.01 22.78 33.14 ns
Hypertension 66 (70.2) 322 (53.3) 0.002
Diabetes Mellitus 35 (37.2) 111 (18.4) <0.001
Cholesterol
> 5.2 mmol/L
71 (75.5) 430 (40.2) ns
HDL-chol
< 0.9 mmol/L
14 (14.9) 42 (7) 0.009
LDL-chol
> 4 mmol/L
18 (19.1) 200 (33.2) ns
Triglycerides
> 2.3 mmol/L
36 (38.3) 70 (11.6) 0.041
Symptomatic CHD 14 (14.9) 48 (7.9) 0.027
Cerebrovascular
Events
8 (8.5) 29 (4.8) ns
Body mass index
(Kg/m2)*
27.32 3.86 27.32 3.5 ns
PAD, peripheral arterial occlusive disease; CHD, coronary heart
disease.
* Mean SD.93.3%; p< 0.001) (Fig. 1). Similarly, CHD related mortality
was higher within PAD subjects (8.6% vs 1.4%; p< 0.001)
(Fig. 2).
At 5-years, all-cause mortality was 15.3% in subjects
without PAD, 27.2% in the asymptomatic PAD group and
37.7% in the symptomatic PAD group. Survival curves were
calculated by KaplaneMeier method, showing a 92.9%
survival ratio at 5 years for subjects without PAD, 83.5%
for asymptomatic and 72.6% for symptomatic PAD patients.
Differences among survival curves were statistically signif-
icant (p< 0.01) (Fig. 3).
To further evaluate the association between PAD and
MCEs, a proportional hazards Cox model was fitted. In the
final model PAD (RRZ 3; pZ 0.003) and previous symptom-
atic CHD (RRZ 4.1; p< 0.001) at baseline examination
were independently associated with MCE during the fol-
low-up after adjusting for diabetes mellitus, LDL-choles-
terol plasma levels and age (Table 3). The relative risk of
future MCE was 2.83 (pZ 0.036) for the group with ABI
0.61e0.9 ABI and 7.83 (p< 0.01) for the group with
ABI 0.6.Discussion
Over the last decade, much effort has been placed on
identifying people at high risk of cardiovascular morbidity
and mortality in Northern countries. Based on epidemiolog-
ical studies, several formulae and scores to predict individ-
uals’ cardiovascular risk according to conventional risk
factors have been developed.15 Consequently, different pri-
mary and secondary preventive strategies have emerged.
However, these strategies may raise unjustifiably health ex-
penditureswhenapplied inpopulationswith low incidenceof
CHD,e.gMediterranean countries.With this purpose inmind,
Marrugat et al.16,17 adapted the Framingham CHD risk score
for the Girona population (Northeast of Spain).
No matter what the incidence of CHD, risk prediction
probably could be improved by incorporating new risk
factors to existing scores. This possibility appears to be
Figure 1 KaplaneMeier coronary major event free survival rates for subjects with and without peripheral arterial occlusive dis-
ease (PAD).
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of CHD. Several epidemiological studies have demonstrated
PAD to be a powerful predictor of both CHD and mortal-
ity.3,18e22 For this reason it has been suggested that PAD,
which can measured easily and non-invasively by ABI, might
be used along with other classical risk factors to stratify in-
dividual risk and to screen and target older adults for more
aggressive risk factor intervention. Nevertheless, the asso-
ciation between PAD and CHD has only been demonstrated
in studies performed in settings with high incidence of car-
diovascular events.Figure 2 KaplaneMeier coronary-related death free survival rat
disease (PAD).Our study was performed within a Mediterranean men
population of the Northeast of Spain. In previous studies,
CHD incidence in this areas has been shown to be 2- to 4-
fold lower than in Northern Europe or the USA.1,2,11,23,24
Our data confirm the low incidence of CHD in a Spanish pop-
ulation. However, the data also show a 3-fold higher risk of
future MCE in subjects with PAD at baseline, which is similar
to the findings. From Northern Europea2,18 and the USA.1,24
This is unlikely to be due to the under-treatment of those
with PAD. The getABI study recently showed an association
between PAD and all-cause mortality.25 Although thees for subjects with and without peripheral arterial occlusive
Figure 3 Survival curves in subjects with and without peripheral arterial occlusive disease (PAD).
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of the inclusion of women, the results were in the same di-
rection as our study, suggesting that screening PAD could be
indicated in elderly patients. In other populations, includ-
ing those with very low CHD incidence, the association
between PAD and CHD risk remains unknown.
The present study has two important limitationsrelating
to the study population: sample size and age-sex charac-
teristics. Our results are only applicable to older men.
Further research is needed to evaluate the association of
PAD with future CHD events in subjects with lower PAD
incidence, such as women and younger subjects. However
our results clearly show that even in areas with low CHD
incidence, PAD remains a strong predictive factor for future
coronary events, as has been demonstrated in other
populations. This finding may be particularly helpful to
develop primary prevention strategies.Table 3 Relative risk of MCE during follow-up according
to risk factors
Relative risk P value
PAD 3 0.003
CHD 4.1 <0.001
Diabetes Mellitus 1.9 0.06
LDL-chol> 4 mmol/l 1.8 0.09
Age> 70 years-old 1.8 0.06
MCE, coronary major event; RR, relative risk; PAD, peripheral
arterial occlusive disease; CHD, coronary heart disease.References
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